The cross-functional AI buying committee

If you're evaluating AI-powered employee benefits solutions, chances are good your HR team isn’t the only party involved in making the decision. The moment "artificial intelligence" and "employee health data" show up in the same sentence, the stakes get higher, the buying process becomes more complex, and more decision-makers enter the room.

CONSIDER THESE STATS:

• When a purchase includes generative AI features, the buying group doubles in size compared to purchases that don't—and complex enterprise deals already involve well over a dozen stakeholders. (Forrester)

• Companies that lead in AI are 1.5 times as likely to have a cross-functional AI governance board. (PwC)

• Over three-quarters (77 percent) of organizations are currently working on AI governance—which involves hiring new or dedicating existing employees to an AI governance team—with a jump to near 90 percent for those organizations already using AI. (IAPP and Credo AI)

Taking a committee approach isn't bureaucracy for its own sake. It's a sign the category has matured—and that organizational leadership teams are prioritizing AI tech purchases as strategic investments that have the potential to have significant impact across the enterprise.

What’s more, consensus is a safeguard, and the data shows it's healthy, not just cautious. Among Forrester respondents with six or more stakeholders in their B2B buying group, 94 percent said the larger group delivered clear benefits—broader perspectives, shared validation, lower risk of a bad decision, and easier budget approval—while fewer than half cited added complexity or slower decisions as real drawbacks.

THE SIX SEATS AT THE TABLE
We have identified six distinct stakeholders who expect a place on the AI Buying Committee before any tech deal gets signed. Here's who's in the room, what they actually care about, and what separates a solution that's ready for this conversation from one that isn't.

HR Leadership (VP of Total Rewards, Benefits Manager, CHRO)

• Wants relief for a team buried in repetitive Tier-1 questions (e.g., deductibles, ID cards, life events) without losing employee trust in the process.
• Cares about whether an AI tool actually drives utilization of the benefits already being paid for, not just another portal employees ignore.
• Will ask: can this handle our real plan complexity (union vs. non-union, multi-tiered deductibles) and cite its sources, or is it guessing?
  
  
  
  

Benefits Broker / Consultant

• Focused on bending the healthcare cost curve for their client and steering people to lower-acuity care before claims spike.
• Worried about fiduciary and compliance exposure they'd be on the hook for recommending.
• Will ask: does this require ripping out our existing carrier or TPA relationships, or does it sit cleanly on top of what's already there?
  
  
  
  

CISO / InfoSec Lead

• Focused entirely on where employee health data lives, how it's encrypted, and whether it ever touches a public AI model.
• Wants proof, not assurances: independent audits, penetration testing, documented architecture.
• Will ask: is our proprietary data ever used to train an external model, and. can I see the SOC 2 report?
  
  
  
  

Legal Counsel / Data Privacy Officer

• Concerned with ERISA fiduciary liability—is this tool a neutral information source, or is it quietly making decisions it has no legal standing to make?
• Wants every AI answer traceable back to an actual plan document, not generated from thin air.
• Will ask: does this operate as a "glass box" that cites its sources, or a black box we'd have to defend in an audit?
  
  
  
  

IT Architecture / Systems Integration Lead

• Cares about how much of their team's time this actually consumes—weeks, not months.
• Wants standard SSO and eligibility-file syncs, not custom engineering or a database rebuild.
• Will ask: who maintains this when plan documents change next year, my team or theirs?
  
  
  

CFO / VP of Finance

• Uninterested in engagement metrics; wants hard-dollar impact tied to specific budget lines.
• Focused on payback timeline and total cost of ownership versus building something internally.
• Will ask: what's the ROI model, and how fast do we see it—90 days, or 18 months?
  
  

What AI-readiness actually looks like

If you look closely, the questions aren't really about features. They're about trust, in six different currencies:

• Clinical trust from HR
• Cost trust from the broker
• Data trust from the CISO
• Legal trust from counsel
• Operational trust from IT
• Financial trust from the CFO

A solution built for this moment tends to share a few traits regardless of vendor: it can point to independent security testing rather than just claiming compliance. It cites its own answers back to real plan documents instead of generating something that sounds plausible. It integrates through standard file syncs and SSO rather than a months-long engineering slog. And it can show a dollar figure tied to a specific budget line—HR labor hours, ticket volume, claims deflection—and not just a satisfaction score.

These are the table stakes for AI touching health data.

A crowded table is a sign of maturity

The six-person committee isn't a hurdle standing between you and a good tool. It's the market correcting itself, treating AI in benefits with the seriousness that handling someone's health information actually deserves. Consensus takes longer than a single signature, but it also catches what a single signature would have missed.

So before you build a shortlist, ask yourself the harder question: if you put your top candidate in front of all six of these stakeholders, one after another, would it hold up?